High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes
暂无分享，去创建一个
P. Thall | R. Orlowski | Y. Nieto | U. Popat | Q. Bashir | M. Qazilbash | J. Jorgensen | R. Champlin | R. Delgado | P. Lin | Sheeba K. Thomas | D. Weber | E. Manasanch | D. Milton | C. Hosing | K. Patel | N. Shah | K. Sasaki | Bei Hu